Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH

Currency In CNY

AD

Valuation

Market Cap25.17B
Enterprise Value32.33B
P/E Ratio68.54
PEG Ratio-1
Price/Sales Ratio2.95
Price/Book Ratio2.55
Enterprise/Revenue3.8
Enterprise/EBITDA28.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue8.54B
Revenue/Share5.74
Gross Profit4.7B
EBITDA1.59B
Net Income266.94M
Diluted EPS0.18

Balance Sheet

Total Cash1.97B
Total Cash/Share1.33
Total Debt9.21B
Total Debt/Equity0.94
Current Ratio1.01
Book Value Per Share6.61

Price History

52-Week Change-19.77
52-Week High27.97
52-Week Low13.73
Moving Average 50 Days15.62
Moving Average 200 Days16.8

Statistics

Average Volume27.67M
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.59
Payout Ratio0.38
Last Split Factor11:10
Last Split DateJune 08, 2020
AD